SLOAN SHELDON (Chief Medical Officer) sold 8.33K shares of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $730.9K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/3/2026ACC: 0001636282-26-000087
Officer· Chief Medical Officer
Since Oct 2024
-8.33K
Net shares
Net seller
$730.9K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
8.33K acquired · 16.67K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+8.33K
Price / share
$27.46
Trade value
$228.85K
% of position
New position
7/1/2026
0.00→8.33K
Common Stock
Direct
Shares
−6.50K
Price / share
$87.52
Trade value
$568.88K
% of position
78.0%
7/1/2026
8.33K→1.83K
Common Stock
Direct
Shares
−1.83K
Price / share
$88.34
Trade value
$162.02K
% of position
New position
7/1/2026
1.83K→0.00
Total
Net shares
+0.00
Net value
-$502.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | M · Option Exercise | +8.33K | $27.46 | $228.85K | New position | 0.00 | 8.33K |
| Common Stock Direct | 7/1/2026 | S · Sale | −6.50K | $87.52 | $568.88K | 78.0% | 8.33K | 1.83K |
| Common Stock Direct | 7/1/2026 | S · Sale | −1.83K | $88.34 | $162.02K | New position | 1.83K | 0.00 |
| Total | +0.00 | -$502.04K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
8.33K shares
Shares
−8.33K
Strike price
27.46
Held after
305K
Exercisable
—
7/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock8.33K shares | 7/1/2026 | M · Option Exercise | −8.33K | 27.46 | — | 305K |